Indolinone Derivatives Inhibit Constitutively Activated KIT Mutants and Kill Neoplastic Mast Cells
- 1 February 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 114 (2) , 392-394
- https://doi.org/10.1046/j.1523-1747.2000.00888.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibition of Spontaneous Receptor Phosphorylation by Residues in a Putative α-Helix in the KIT Intracellular Juxtamembrane RegionPublished by Elsevier ,1999
- Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosisProceedings of the National Academy of Sciences, 1999
- Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell NeoplasmsJournal of Investigative Dermatology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with InhibitorsScience, 1997
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Establishment of Two Dog Mastocytoma Cell Lines in Continuous CultureAmerican Journal of Respiratory Cell and Molecular Biology, 1990
- Primary structure and functional expression of rat and human stem cell factor DNAsCell, 1990
- Isolated canine mastocytoma cells: propagation and characterization of two cell linesAmerican Journal of Physiology-Cell Physiology, 1986